Literature DB >> 23535575

L74V increases the reverse transcriptase content of HIV-1 virions with non-nucleoside reverse transcriptase drug-resistant mutations L100I+K103N and K101E+G190S, which results in increased fitness.

Jiong Wang1, Dongge Li1, Robert A Bambara2, Hongmei Yang3, Carrie Dykes1.   

Abstract

The fitness of non-nucleoside reverse transcriptase inhibitor (NNRTI) drug-resistant reverse transcriptase (RT) mutants of HIV-1 correlates with the amount of RT in the virions and the RNase H activity of the RT. We wanted to understand the mechanism by which secondary NNRTI-resistance mutations, L100I and K101E, and the nucleoside resistance mutation, L74V, alter the fitness of K103N and G190S viruses. We measured the amount of RT in virions and the polymerization and RNase H activities of mutant RTs compared to wild-type, K103N and G190S. We found that L100I, K101E and L74V did not change the polymerization or RNase H activities of K103N or G190S RTs. However, L100I and K101E reduced the amount of RT in the virions and subsequent addition of L74V restored RT levels back to those of G190S or K103N alone. We conclude that fitness changes caused by L100I, K101E and L74V derive from their effects on RT content.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535575      PMCID: PMC3709637          DOI: 10.1099/vir.0.050914-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val.

Authors:  P L Sharma; C S Crumpacker
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions.

Authors:  Jiong Wang; Robert A Bambara; Lisa M Demeter; Carrie Dykes
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  HIV-1 reverse transcriptase mutants resistant to nonnucleoside reverse transcriptase inhibitors do not adversely affect DNA synthesis: pre-steady-state and steady-state kinetic studies.

Authors:  Robert A Domaoal; Robert A Bambara; Lisa M Demeter
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-01       Impact factor: 3.731

4.  HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.

Authors:  Paula C Aulicino; Carlos A Rocco; Debora Mecikovsky; Rosa Bologna; Andrea Mangano; Luisa Sen
Journal:  Antivir Ther       Date:  2010

Review 5.  Rationale and uses of a public HIV drug-resistance database.

Authors:  Robert W Shafer
Journal:  J Infect Dis       Date:  2006-09-15       Impact factor: 5.226

6.  Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.

Authors:  M I Bukrinsky; N Sharova; T L McDonald; T Pushkarskaya; W G Tarpley; M Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.

Authors:  J Ding; K Das; Y Hsiou; S G Sarafianos; A D Clark; A Jacobo-Molina; C Tantillo; S H Hughes; E Arnold
Journal:  J Mol Biol       Date:  1998-12-11       Impact factor: 5.469

8.  Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.

Authors:  B Chesebro; K Wehrly; J Nishio; S Perryman
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Human immunodeficiency virus reverse transcriptase and protease sequence database.

Authors:  Soo-Yon Rhee; Matthew J Gonzales; Rami Kantor; Bradley J Betts; Jaideep Ravela; Robert W Shafer
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

10.  Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.

Authors:  K Toohey; K Wehrly; J Nishio; S Perryman; B Chesebro
Journal:  Virology       Date:  1995-10-20       Impact factor: 3.616

View more
  2 in total

1.  Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain.

Authors:  Jessica R Keys; Shuntai Zhou; Jeffrey A Anderson; Joseph J Eron; Lauren A Rackoff; Cassandra Jabara; Ronald Swanstrom
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-02       Impact factor: 2.205

2.  A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host.

Authors:  Alison F Feder; Christopher Kline; Patricia Polacino; Mackenzie Cottrell; Angela D M Kashuba; Brandon F Keele; Shiu-Lok Hu; Dmitri A Petrov; Pleuni S Pennings; Zandrea Ambrose
Journal:  PLoS Pathog       Date:  2017-05-25       Impact factor: 6.823

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.